Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Laboratory investigation; a journal of technical methods and pathology

• Publication date

  1993-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8377473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simultaneous expression of 70 kilodalton type IV collagenase and type IV collagen alpha 1 (IV) chain genes by cells of early human placenta and gestational endometrium.

  1992cited by this paper
• Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development.

  1992cited by this paper
• Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.

  1992cited by this paper
• Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia.

  1992cited by this paper
• Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase.

  1992cited by this paper
• Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

  1991cited by this paper
• Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

  1991cited by this paper
• Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.

  1990cited by this paper
• Type IV collagenases in tumor invasion and metastasis

  1990cited by this paper
• Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.

  1990cited by this paper
• A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

  1990cited by this paper
• Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16.

  1990cited by this paper
• Extraction of type‐IV collagenase/gelatinase from plasma membranes of human cancer cells

  1990cited by this paper
• Cell-matrix interactions during tumor invasion

  1990cited by this paper
• Structure of the human type IV collagenase gene.

  1990cited by this paper
• Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.

  1989cited by this paper
• Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G

  1989cited by this paper
• SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

  1989cited by this paper
• From tadpole collagenase to a family of matrix metalloproteinases.

  1988cited by this paper
• The collagenase gene family in humans consists of at least four members.

  1988cited by this paper
• H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

  1988cited by this paper
• Activation of human neutrophil gelatinase by endogenous serine proteinases.

  1988cited by this paper
• Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells.

  1987cited by this paper
• Proteolytic degradation of extracellular matrix in tumor invasion.

  1987cited by this paper
• Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts

  1986cited by this paper
• Comparison of human stromelysin and collagenase by cloning and sequence analysis.

  1986cited by this paper
• Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein.

  1986cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• cDNA clones coding for the pro-alpha1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain.

  1985cited by this paper
• Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase.

  1984cited by this paper
• Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells.

  1983cited by this paper
• Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis

  1982cited by this paper
• Metastatic potential correlates with enzymatic degradation of basement membrane collagen

  1980cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper

• Interaction of oxytetracycline and bacterial collangenase in the treatment of bovine retained placenta

  2022cites this paper
• The Role of the Tumor Stroma in Ovarian Cancer

  2014cites this paper
• Effects of TRPC6 on invasibility of low-differentiated prostate cancer cells.

  2014cites this paper
• Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma

  2013cites this paper
• Gelatinasas (MMP-2, MMP-9) e inhibidor tisular de metaloproteinasas tipo 2 (TIMP-2) como marcadores de diagnóstico y pronóstico en el cáncer de vejiga

  2013cites this paper
• Papel do polimorfismo genético na expressão das metaloproteases na tendinopatia primária do tendão tibial posterior

  2011cites this paper
• Invasion and Metastasis

  2010cites this paper
• The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis.

  2010cites this paper
• The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

  2008cites this paper
• Prognostic Significance of Cell-Matrix Interactions in Epithelial Ovarian Cancer

  2007cites this paper
• Anatomic site-related expression of cancer-associated molecules in ovarian carcinoma.

  2007cites this paper
• Cell adhesion and matrixassociated proteins in ovarian carcinoma

  2007cites this paper
• Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system.

  2007cites this paper
• Metalloproteinases and their inhibitors: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas

  2006cites this paper
• Matrix metalloproteinases‐2 and ‐9 in cervical cancer: different roles in tumor progression

  2006cites this paper
• The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

  2006cites this paper
• Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers.

  2005cites this paper
• Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma.

  2005cites this paper
• Type IV collagenases in invasive tumors

  2005cites this paper
• Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression

  2005cites this paper
• Matrix Metalloproteinase-2 (MMP-2) in T1–2N0 breast carcinoma

  2004cites this paper
• Role of Matrix Metalloproteinases in Bone Metastasis from Human Breast and Prostate Cancer

  2004cites this paper
• Matrix Metalloproteinase 2 (MMP-2) Immunoreactive Protein is Associated with Poor Grade and Survival in Brain Neoplasms

  2004cites this paper
• Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.

  2004cites this paper
• TGFβ1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103

  2004cites this paper
• Role of the extracellular matrix in the degradation of connective tissue

  2004cites this paper
• Comparison of carboxyterminal telopeptide of type I collagen (ICTP) and CA 125 as predictors of prognosis in ovarian cancer.

  2004cites this paper
• High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

  2004influential citation
• Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage.

  2004cites this paper
• Effect of transforming growth factor-beta1, interleukin-6, and interferon-gamma on the expression of type I collagen, heat shock protein 47, matrix metalloproteinase (MMP)-1 and MMP-2 by fibroblasts from normal gingiva and hereditary gingival fibromatosis.

  2003cites this paper
• MATRIX METALLOPROTEINASE-2 (MMP-2) AND -9 (MMP-9) IN HEMATOLOGICAL MALIGNANCIES

  2003cites this paper
• Participation of fibroblasts in MMP-2 binding and activation on the surface of oral squamous cell carcinoma cells.

  2003cites this paper
• Matrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma.

  2003cites this paper
• Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer.

  2002cites this paper
• Angiogenesis and metastasis.

  2002cites this paper
• Expression of Ets-related Transcription Factors and Matrix Metalloproteinase Genes in Human Breast Cancer Cells

  2002cites this paper
• Expression of matrix metalloproteinases-2 and -9 by cells isolated from the peritoneal fluid of women with ovarian carcinoma.

  2002cites this paper
• Expression of Matrix Metalloproteinases in Cyclosporin-Treated Gingival Fibroblasts Is Regulated by Transforming Growth Factor (TGF)-β1 Autocrine Stimulation

  2002cites this paper
• MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study.

  2002cites this paper
• ETS proteins and MMPs: partners in invasion and metastasis.

  2002cites this paper
• Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.

  2002cites this paper
• Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.

  2001cites this paper
• Analyses of Matrix Metalloproteinases and Their Inhibitors in Cyst Fluid of Serous Ovarian Tumors

  2001cites this paper
• Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12‐9566 phase I study

  2001cites this paper
• Cloning and characterization of Vear, a novel Golgi-associated protein involved in vesicle trafficking

  2001cites this paper
• ENHANCE DINVASIVENES SO FPANCREATI CADENOCARCINOM ACELLS STABL YTRANSFECTE DWIT HCATIONI CTRYPSINOGE NcDNA

  2001cites this paper
• The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation

  2001influential citation
• Ovarian Carcinoma and Serous Effusions. Changing Views Regarding Tumor Progression and Review of Current Literature

  2001cites this paper
• Podocyte-specific expression of a novel trans-Golgi protein Vear in human kidney.

  2001cites this paper
• Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography.

  2001cites this paper
• Serous tumors of low malignant potential of the ovary-molecular pathology: part 2

  2001cites this paper
• Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.

  2001cites this paper
• Trypsinogens and trypsin inhibitor (PSTI/TATI) -expression in urogenital organs and tumors

  2001influential citation
• Comparative Analysis of the Distribution of Laminin Chains in the Basement Membranes in Some Malignant Epithelial Tumors: The α1 Chain of Laminin Shows a Selected Expression Pattern in Human Carcinomas

  2001cites this paper
• Enhanced invasiveness of pancreatic adenocarcinoma cells stably transfected with cationic trypsinogen cDNA

  2001cites this paper
• TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.

  2000cites this paper
• Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.

  2000cites this paper
• Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.

  2000cites this paper
• Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.

  2000cites this paper
• Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1‐matrix metalloproteinase in esophageal squamous cell carcinomas

  2000cites this paper
• Chapter 15. Matrix metalloproteinase inhibitors for treatment of cancer

  2000cites this paper
• Role of basement membranes and their break-down in human carcinomas : a study by in situ hybridization and immunohistochemistry of the expression of laminin chains, matrix metalloproteinases (MMPs) and their tissue inhibitors of metalloproteinases (TIMPs)

  2000cites this paper
• Angiogenesis and matrix metalloproteinases in non-small cell lung cancer

  2000cites this paper
• Characterization of type I and type III collagens in human tissues

  2000cites this paper
• Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-beta 1 autocrine stimulation.

  1999cites this paper
• Type I and Type III Collagen Metabolites as Predictors of Clinical Outcome in Epithelial Ovarian Cancer

  1999cites this paper
• Matrix metalloproteinases: Regulation and biological functions

  1999cites this paper
• A human seminoma xenograft model with regional lymph node metastasis.

  1999cites this paper
• Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation.

  1999cites this paper
• Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas.

  1999cites this paper
• Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.

  1999cites this paper
• Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer.

  1999cites this paper
• Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

  1999cites this paper
• MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma

  1999cites this paper
• Gelatinase A-immunoreactive protein in ovarian lesions- prognostic value in epithelial ovarian cancer.

  1999cites this paper
• Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.

  1999cites this paper
• Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.

  1999cites this paper
• Matrix metalloproteinases in tumour invasion and metastasis

  1999cites this paper
• Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study

  1999cites this paper
• The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer

  1999cites this paper
• Chapter 13 - Matrix Metalloproteinase Inhibitors and Cancer

  1998cites this paper
• MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts.

  1998cites this paper
• Evaluation of inhibitory effects of doxorubicin on collagenase using a bovine placentome model.

  1998cites this paper
• The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma.

  1998cites this paper
• 72-kDa Gelatinase (Gelatinase A): Structure, Activation, Regulation, and Substrate Specificity

  1998cites this paper
• Production of Membrane-type Matrix Metalloproteinase-1 (MT-MMP-1) in Early Human Placenta: A Possible Role in Placental Implantation?

  1998cites this paper
• Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

  1998cites this paper
• Pre‐operative serum level of tumour‐associated trypsin inhibitor and residual turnour size as prognostic indicators in Stage III epithelial ovarian cancer

  1998cites this paper
• Differential expression of trypsin in human ovarian carcinomas and low-malignant-potential tumors.

  1998cites this paper
• Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.

  1998cites this paper
• Matrix metalloproteinase‐2 immunoreactive protein

  1998cites this paper
• Production of extracellular matrix‐degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells

  1997cites this paper
• Dual expression of matrix metalloproteinase‐2 and membrane‐type 1‐matrix metalloproteinase in fibrotic human livers

  1997cites this paper
• An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells

  1997cites this paper
• Expression of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Head and Neck Squamous Cell Carcinoma

  1997cites this paper
• Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues.

  1997cites this paper
• In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer

  1997cites this paper
• Ovarian cancer cell invasion is inhibited by paclitaxel

  1997cites this paper
• The multiple roles of tumour stroma

  1997cites this paper
• Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2).

  1997cites this paper